Cambium Bio
Blood & Organ Banks · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
16 Goodhope St, Paddington, New South Wa...Phone Number
+61 1300995098Website
cambium.bioRevenue
<$5 MillionStock Symbol
CMBIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
1
1
About Cambium Bio
Cambium Bio is a Sydney-based clinical-stage regenerative medicine company focusing on the development of innovative biologics for ophthalmology and tissue regeneration applications. The Company's proprietary technology, based on human platelet lysate, is being leveraged to create a pipeline of novel therapeutics with a primary focus on ophthalmology.Explore more
Cambium Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cambium Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Cambium Bio had a recent Job posting/layoffs
Earning: See what the market has to say on Cambium Bio recently announced quarterly report
Funding: Get notified immidiatlly once Cambium Bio has new funding data
Check if Cambium Bio has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Cambium Bio launches new products
Congratulate Masked Content for being promoted to Masked Content at Cambium Bio
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Cambium Bio is spiking on competitors!
Website visits: Recent activity has been detected on your website
Cambium Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Cambium Bio is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Cambium Bio is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Cambium Bio.
Cambium Bio financials insights
Gather financial insights about Cambium Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Private Equity
$1.9M
Cambium Bio Tech Stack
A closer look at the technologies used by Cambium Bio
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Partnership, Pharmaceuticals, Healthcare Technology, Manufacturing Operations
Funding
Funding
Funding
Cambium Bio News & Media
Locus Cell's Zhubei Smart GMP Facility Secures First International Phase III CDMO Manufacturing MOU with Cambium Bio
TAIPEI, Sept. 29, 2025 /PRNewswire/ -- Locus Cell (TWSE: 6891), a leading regenerative medicine CDMO in Taiwan, announced it has signed a Memorandum of Understanding (MOU) with Australia-based Cambium Bio (ASX: CMB). Under the agreement, Cambium will entrust Locus Cell with the contract...Cambium Bio Secures A$2.12 Million in Fully-Subscribed Placement - Sharecafe
Cambium Bio Limited (ASX:CMB), a clinical-stage regenerative medicine company focused on ophthalmology and tissue repair, has announced it has successfully raised A$2,119,418 through a placement of 4,570,667 new fully-paid ordinary shares. The placement utilised the company’s existing 15% placement capacity under ASX Listing Rule 7.1 and additional 10% capacity under Listing Rule 7.1A. The sharesCambium Bio Successfully Closes A$3.0M Financing Round
Cambium Bio Successfully Closes A$3.0M Financing Round
Read more news
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Cambium Bio
Sign Up For FreeTo access detailed company insights
Cambium Bio is a Sydney-based clinical-stage regenerative medicine company focusing on the development of innovative biologics for ophthalmology and tissue regeneration applications. The Company's proprietary technology, based on human platelet lysate, is being leveraged to create a pipeline of novel therapeutics with a primary focus on ophthalmolo... Read More
